| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 620385 | 42846 | ARTRINOVO 100 MG SUPOSITORIOS | ARTRINOVO 100 MG SUPOSITORIOS, 100 supositorios | 100 mg | 5 | 100 | 33 | 100 supositorios | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/42846/42846_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/42846/42846_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 8306 | LABORATORIOS LLORENS S.L. | 1966-05-01 | 1 | 1 | 1 | 1966-05-01 | 1966-05-01 | 1 | 2011-10-28 | View Edit Delete | ||||||||||||
| 620393 | 43857 | ARTRINOVO 50 MG SUPOSITORIOS | ARTRINOVO 50 MG SUPOSITORIOS, 100 supositorios | 50 mg | 5 | 100 | 33 | 100 supositorios | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/43857/43857_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/43857/43857_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 8306 | LABORATORIOS LLORENS S.L. | 1966-12-01 | 1 | 1 | 1 | 1966-12-01 | 1966-12-01 | 1 | 2011-10-28 | View Edit Delete | ||||||||||||
| 620427 | 48194 | DOSIL 100 MG CÁPSULAS DURAS | DOSIL 100 MG CÁPSULAS DURAS , 500 cápsulas | 100 mg | 5 | 500 | 43 | 500 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/48194/48194_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/48194/48194_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 8306 | LABORATORIOS LLORENS S.L. | 1969-11-01 | 1 | 1 | 1 | 1969-11-01 | 1969-11-01 | 1 | 2011-10-28 | View Edit Delete | ||||||||||||
| 607345 | 85080 | METAMIZOL VIR 575 MG CAPSULAS DURAS EFG | METAMIZOL VIR 575 MG CAPSULAS DURAS EFG, 500 cápsulas | 575 mg | 5 | 500 | 43 | 500 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85080/85080_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85080/85080_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 3050 | INDUSTRIA QUIMICA Y FARMACEUTICA VIR S.A. | 2020-05-13 | 1 | 1 | 1 | 2020-05-14 | 2020-05-13 | 0 | 2020-09-30 | View Edit Delete | ||||||||||||
| 610873 | 62708 | CIPROFLOXACINO VIR 500 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | CIPROFLOXACINO VIR 500 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 500 comprimidos | 500 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62708/62708_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62708/62708_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 3050 | INDUSTRIA QUIMICA Y FARMACEUTICA VIR S.A. | 1999-08-01 | 1 | 1 | 1 | 1999-08-01 | 1999-09-01 | 0 | 2011-06-08 | View Edit Delete | ||||||||||||
| 612200 | 64638 | CLARITROMICINA VIR 500 mg comprimidos recubiertos EFG | CLARITROMICINA VIR 500 mg comprimidos recubiertos EFG, 500 comprimidos | 500 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64638/64638_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64638/64638_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 3050 | INDUSTRIA QUIMICA Y FARMACEUTICA VIR S.A. | 2002-03-20 | 1 | 1 | 1 | 2002-03-20 | 2002-03-20 | 1 | 2011-10-27 | View Edit Delete | ||||||||||||
| 612218 | 64639 | CLARITROMICINA VIR 250 mg comprimidos recubiertos EFG | CLARITROMICINA VIR 250 mg comprimidos recubiertos EFG, 500 comprimidos | 250 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64639/64639_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64639/64639_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 3050 | INDUSTRIA QUIMICA Y FARMACEUTICA VIR S.A. | 2002-03-18 | 1 | 1 | 1 | 2002-03-18 | 2002-03-18 | 1 | 2015-10-28 | View Edit Delete | ||||||||||||
| 612622 | 66131 | SERTRALINA VIR PHARMA 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | SERTRALINA VIR PHARMA 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 500 comprimidos | 50 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66131/66131_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66131/66131_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 3050 | INDUSTRIA QUIMICA Y FARMACEUTICA VIR S.A. | 2004-05-28 | 1 | 1 | 1 | 2004-05-28 | 2004-05-28 | 1 | 2014-04-29 | View Edit Delete | ||||||||||||
| 618934 | 62966 | CIPROFLOXACINO VIR, 250 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | CIPROFLOXACINO VIR, 250 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 500 comprimidos | 250 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62966/62966_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62966/62966_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 3050 | INDUSTRIA QUIMICA Y FARMACEUTICA VIR S.A. | 2000-03-21 | 1 | 1 | 1 | 2000-03-21 | 2000-03-21 | 0 | 2011-06-08 | View Edit Delete | ||||||||||||
| 620773 | 63907 | LOVASTATINA VIR 40 mg COMPRIMIDOS EFG | LOVASTATINA VIR 40 mg COMPRIMIDOS EFG , 500 comprimidos | 40 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63907/63907_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63907/63907_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 3050 | INDUSTRIA QUIMICA Y FARMACEUTICA VIR S.A. | 2001-05-21 | 1 | 1 | 1 | 2001-05-21 | 2001-05-21 | 1 | 2011-06-08 | View Edit Delete | ||||||||||||
| 621243 | 63153 | DOXAZOSINA VIR 2 mg COMPRIMIDOS EFG | DOXAZOSINA VIR 2 mg COMPRIMIDOS EFG , 500 comprimidos | 2 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63153/63153_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63153/63153_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 3050 | INDUSTRIA QUIMICA Y FARMACEUTICA VIR S.A. | 2000-05-30 | 1 | 1 | 1 | 2000-05-30 | 2000-05-30 | 1 | 2014-04-29 | View Edit Delete | ||||||||||||
| 621250 | 63154 | DOXAZOSINA VIR 4 mg COMPRIMIDOS EFG | DOXAZOSINA VIR 4 mg COMPRIMIDOS EFG , 500 comprimidos | 4 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63154/63154_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63154/63154_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 3050 | INDUSTRIA QUIMICA Y FARMACEUTICA VIR S.A. | 2000-05-30 | 1 | 1 | 1 | 2000-05-30 | 2000-05-30 | 1 | 2014-04-29 | View Edit Delete | ||||||||||||
| 607857 | 78279 | ATORVASTATINA PHARMA COMBIX 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA PHARMA COMBIX 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 100 comprimidos | 20 mg | 5 | 100 | 10 | 100 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78279/78279_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78279/78279_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 12564 | LABORATORIOS COMBIX S.L.U. | 2013-12-05 | 1 | 1 | 1 | 2013-12-05 | 2025-02-10 | 1 | 2026-04-09 | View Edit Delete | ||||||||||||
| 607858 | 78280 | ATORVASTATINA PHARMA COMBIX 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA PHARMA COMBIX 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 100 comprimidos | 40 mg | 5 | 100 | 10 | 100 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78280/78280_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78280/78280_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 12564 | LABORATORIOS COMBIX S.L.U. | 2013-12-05 | 1 | 1 | 1 | 2013-12-05 | 2025-02-10 | 1 | 2026-04-09 | View Edit Delete | ||||||||||||
| 607859 | 78281 | ATORVASTATINA PHARMA COMBIX 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA PHARMA COMBIX 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 90 comprimidos | 80 mg | 5 | 90 | 10 | 90 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78281/78281_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78281/78281_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 12564 | LABORATORIOS COMBIX S.L.U. | 2013-12-05 | 1 | 1 | 1 | 2013-12-05 | 2025-02-10 | 1 | 2026-04-09 | View Edit Delete | ||||||||||||
| 620021 | 65186 | OMEPRAZOL KORHISPANA 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | OMEPRAZOL KORHISPANA 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG , 500 cápsulas | 20 mg | 5 | 500 | 43 | 500 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/65186/65186_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/65186/65186_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 10651 | KORHISPANA S.L. | 2003-02-03 | 1 | 1 | 1 | 2003-02-03 | 2003-02-03 | 1 | 2011-04-28 | View Edit Delete | ||||||||||||
| 607421 | 83864 | METFORMINA KERN PHARMA 850 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | METFORMINA KERN PHARMA 850 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG,500 comprimidos | 850 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83864/83864_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83864/83864_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2019-02-25 | 1 | 1 | 1 | 2019-02-26 | 2021-02-16 | 0 | 2022-06-09 | View Edit Delete | ||||||||||||
| 607453 | 39692 | DIAZEPAN PRODES 10 mg COMPRIMIDOS | DIAZEPAN PRODES 10 mg COMPRIMIDOS,100 comprimidos | 10 mg | 5 | 100 | 10 | 100 comprimidos | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/39692/39692_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/39692/39692_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 1964-05-01 | 1 | 1 | 1 | 1964-05-01 | 2021-09-29 | 1 | 2022-04-12 | Lista IV | View Edit Delete | |||||||||||
| 607454 | 39693 | DIAZEPAN PRODES 5 mg COMPRIMIDOS | DIAZEPAN PRODES 5 mg COMPRIMIDOS,100 comprimidos | 5 mg | 5 | 100 | 10 | 100 comprimidos | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/39693/39693_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/39693/39693_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 1964-05-01 | 1 | 1 | 1 | 1964-05-01 | 2021-09-29 | 1 | 2021-12-14 | Lista IV | View Edit Delete | |||||||||||
| 607482 | 69620 | FUROSEMIDA KERN PHARMA 40 mg COMPRIMIDOS EFG | FUROSEMIDA KERN PHARMA 40 mg COMPRIMIDOS EFG, 100 comprimidos | 40 mg | 5 | 100 | 10 | 100 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69620/69620_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69620/69620_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2008-02-20 | 1 | 1 | 1 | 2008-02-20 | 2022-03-01 | 1 | 2022-10-11 | View Edit Delete |
Page 30 of 1035, showing 20 records out of 20697 total, starting on record 581, ending on 600